Justine O'Malley
Investor Relations Kontakt bei PROTARA THERAPEUTICS, INC.
Ursprung des Netzwerks ersten Grades von Justine O'Malley
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 18 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Justine O'Malley
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Pharmaceuticals: Major | Chairman Director/Board Member Director/Board Member Director/Board Member Director/Board Member Founder Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer Director of Finance/CFO | |
| CAMBREX CORPORATION | Pharmaceuticals: Generic | Director of Finance/CFO Director of Finance/CFO | |
Fluorinov Pharmaceuticals, Inc.
 Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| ENTERA BIO LTD. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| The Pennsylvania State University | College/University | Undergraduate Degree Undergraduate Degree | |
| INCYTE CORPORATION | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Exp@nets, Inc. | Director of Finance/CFO Director of Finance/CFO | ||
| BEIGENE, LTD. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Undergraduate Degree | |
| AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Washington University School of Medicine | College/University | Doctorate Degree | |
| French-American Foundation | Director/Board Member | ||
| SPERO THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| DICERNA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Eagleton Institute of Politics | College/University | Graduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
| AFFYMAX, INC. | Biotechnology | Corporate Officer/Principal | |
| ZS PHARMA INC | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | President | |
| RAFAEL HOLDINGS, INC. | Real Estate Development | President | |
| The Leonard N Stern School of Business | College/University | Masters Business Admin | |
WindMIL Therapeutics, Inc.
 WindMIL Therapeutics, Inc. Medical SpecialtiesHealth Technology WindMIL Therapeutics, Inc. operates as a biotechnology company. It develops immunotherapies for the treatment of cancer patients. The company was founded by Ivan Borrello and Kimberly Noonan and is headquartered in Baltimore, MD. | Medical Specialties | Director of Finance/CFO | |
| BEYONDSPRING INC. | Pharmaceuticals: Major | Director/Board Member | |
Catalent Pharma Solutions, Inc.
 Catalent Pharma Solutions, Inc. Pharmaceuticals: MajorHealth Technology Catalent Pharma Solutions, Inc. engages in the development, manufacture, and sale of pharmaceutical products. It operates through the following segments: Development and Clinical Services, Oral Technologies, and Medication Delivery Solutions. The Development and Clinical Services segment manufactures, packs, stores distributes, and manages inventory for global clinical trials of drugs and biologics. The Oral Technologies segment formulates, develops, and manufactures prescription and consumer health products using various technologies. The Medication Delivery Solutions segment develops, formulates, and manufactures prefilled syringes and other injectable formats. The company was founded in 2002 and is headquartered in Somerset, NJ. | Pharmaceuticals: Major | Director of Finance/CFO | |
| PROGENICS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
| ELECTROCORE, INC. | Medical Specialties | Director of Finance/CFO | |
| Pace University | College/University | Undergraduate Degree | |
Coopers & Lybrand (London)
 Coopers & Lybrand (London) Miscellaneous Commercial ServicesCommercial Services Part of PricewaterhouseCoopers International Ltd., Coopers & Lybrand (London) is a British company that provides accounting services. The company is based in Edinburgh, UK. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
ValenzaBio, Inc.
 ValenzaBio, Inc. BiotechnologyHealth Technology ValenzaBio, Inc. develops safe and effective treatment options for patients with autoimmune and inflammatory diseases. The company is headquartered in Bethesda, MD. | Biotechnology | Director/Board Member | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
858 Therapeutics, Inc.
 858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
| The Johns Hopkins University | College/University | Doctorate Degree | |
| Marymount University | College/University | Graduate Degree | |
| ACORDA THERAPEUTICS, INC. | Pharmaceuticals: Major | Human Resources Officer | |
| University of San Diego | College/University | Undergraduate Degree | |
| Yale University | College/University | Undergraduate Degree | |
| The University of Pennsylvania Law School | College/University | Graduate Degree | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| INTERCEPT PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel | |
| Rochester Christian University | College/University | Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 47 |
| Israel | 2 |
| Cayman Islands | 2 |
| Niederlande | 2 |
| Vereinigtes Königreich | 2 |
Sektoral
| Health Technology | 33 |
| Consumer Services | 15 |
| Finance | 2 |
| Commercial Services | 2 |
Operativ
| Director/Board Member | 50 |
| Corporate Officer/Principal | 40 |
| Independent Dir/Board Member | 25 |
| Director of Finance/CFO | 20 |
| Undergraduate Degree | 16 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Luke Beshar | 19 |
| Richard Levy | 16 |
| Gregory Sargen | 15 |
| Michael Solomon | 14 |
| Patrick Fabbio | 13 |
| Cynthia Smith | 13 |
| Barry Flannelly | 10 |
| Blaine Davis | 10 |
| Jacqueline Zummo | 9 |
| Jane Huang | 8 |
| Roger Garceau | 8 |
| Jesse Shefferman | 7 |
| Jathin Bandari | 7 |
| Mary J. Grendell | 6 |
| Martín Sebastian Olivo | 5 |
- Börse
- Insiders
- Justine O'Malley
- Unternehmensverbindungen
